Malignant Mixed Neoplasm

general

Centers

Active Trials

$4.0B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Ovarian Mixed Germ Cell Tumor	18	—

Top Centers for Malignant Mixed Neoplasm(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	$458M	—
2	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	$454M	—
3	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive	—	$438M	—
4	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	$319M	—
5	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	$276M	—
6	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	$262M	—
7	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	$222M	—
8	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	$216M	—
9	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	$186M	—
10	Cedars-Sinai CancerLos Angeles, CA	—	$179M	—
11	Cleveland Clinic Cancer CenterCleveland, OH	—	$150M	—
12	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	$146M	—
13	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	$134M	—
14	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive	—	$130M	—
15	University of Illinois Cancer CenterChicago, IL	—	$122M	—
16	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	$106M	—
17	Boston University Cancer CenterBoston, MA	—	$98M	—
18	Cancer Center at IllinoisUrbana, IL	—	$81M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →